Boston Scientifics’ Cardiac Rhythm Management (CRM) Group is a leading developer of implantable devices (pacemakers and defibrillators) used to treat cardiac arrhythmias, sudden cardiac arrest, and heart failure.

• Clinical Trial Manager (Aug 2015 – Present)
• Field Clinical Representative, Contract (May 2008 – Dec 2008)
• Field Clinical Representative (Oct 2005 – Apr 2007)
• Boston Scientific Reference Letter

Note: (formerly Covidien, formerly Sapheon)

Sapheon is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. Sapheon was acquired by Covidien in AUG 2014. Covidien was acquired by Medtronic in JAN 2015.

• Clinical Program Manager (Feb 2012 – Aug 2015)
• Medtronic Reference Letter
• VenaSeal Approval

Novella Clinical is the first fully electronic Contract Research Organization (CRO) capable of integrating clinical and technological expertise to completely manage both pharmacological and medical device clinical trials.

• Clinical Project Manager (Dec 2008 – Feb 2013)
• Novella Clinical Reference Letter

Metacure is the developer of TANTALUS, an intelligent medical device that helps diabetic patients control their eating habits, lowering their blood glucose and body weight.

• Field Clinical Engineer (Jun 2007 – Jun 2008)
• MetaCure Reference Letter

EP MedSystems develops, manufactures and markets a line of products for use in the cardiac rhythm management or electrophysiology market which are used for visualization, diagnosis and treatment of cardiac rhythm disorders.

• Field Clinical Engineer (Apr 2005 – Oct 2007)